Fucoxanthin Suppresses Lipid Accumulation and Inflammatory Responses in FFA-Induced Hepatocyte Models via the EGR2-CD36 Axis
Molecules · 10.07.2026 · 31 (14) · 2423
DOI: 10.3390/molecules31142423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 10.07.2026. Verfasst von Xiangyu Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education, Tianjin Key L…. Hauptthemen laut MEDLINE: CD36 Antigens, Early Growth Response Protein 2, Lipid Metabolism, Hepatocytes. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Technology Innovation Program Shenzhen-Hong Kong Joint Project, Technology Innovation Program Shenzhen–Hong Kong Joint Project.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease with limited treatment options. Here, we demonstrate that fucoxanthin (FUCO), a natural marine carotenoid, attenuates free fatty acid (FFA)-induced hepatocellular steatosis and inflammatory responses in vitro by targeting the EGR2-CD36 axis (EGR2, early growth response protein 2; CD36, cluster of differentiation 36). In FFA-induced hepatocyte models (HepG2, Hep3B, and AML12), FUCO significantly reduced lipid accumulation and inflammatory markers without cytotoxicity. Mechanistic studies revealed that FUCO specifically inhibited fatty acid uptake and transport by downregulating CD36, while triglyceride (TG) degradation remained unaffected. RNA sequencing identified EGR2 as a master regulator induced by FFA and suppressed by FUCO. Functional validation showed that EGR2 overexpression completely blocked FUCO’s lipid-lowering effects and restored CD36 expression, confirming that FUCO acts through EGR2-dependent CD36 inhibition. Bioinformatic analysis further supported EGR2-mediated regulation of CD36 via tumor necrosis factor (TNF) and sterol regulatory element-binding factor (SREBF) pathways. Collectively, our findings establish EGR2 as a critical molecular target for FUCO and provide mechanistic insights that may support its further evaluation in preclinical models for MASH therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education, Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, Tianji…
- Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen 518107, China.
- State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
- State Key Laboratory of Ecological Pest Control for Fujian and Taiwan Crops, Fujian Key Laboratory of Pathogenic Fungi and Mycotoxins, School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002,…
- Demeter Biotech Co., Ltd., Zhuhai 519075, China.
ORCID-Profile: Aiqun Yu, Qizhou Lian
Förderung
- National Key Research and Development Program of China
- Technology Innovation Program Shenzhen-Hong Kong Joint Project
- Technology Innovation Program Shenzhen–Hong Kong Joint Project
Zitieren
APA
Li, X., Yang, C., Chen, Q., Xu, X., Wang, L., Zhang, P., Hu, Q., Han, D., Yu, A., Jiang, J., & Lian, Q. (2026). Fucoxanthin Suppresses Lipid Accumulation and Inflammatory Responses in FFA-Induced Hepatocyte Models via the EGR2-CD36 Axis. Molecules, 31(14), 2423. https://doi.org/10.3390/molecules31142423
Vancouver
Li X, Yang C, Chen Q, Xu X, Wang L, Zhang P, et al. Fucoxanthin Suppresses Lipid Accumulation and Inflammatory Responses in FFA-Induced Hepatocyte Models via the EGR2-CD36 Axis. Molecules. 2026;31(14):2423. doi:10.3390/molecules31142423
BibTeX
@article{Li2026,
author = {Li, Xiangyu and Yang, Chen and Chen, Qionghui and Xu, Xianchuan and Wang, Lian and Zhang, Peng and Hu, Qiang and Han, Danxiang and Yu, Aiqun and Jiang, Jing and Lian, Qizhou},
title = {Fucoxanthin Suppresses Lipid Accumulation and Inflammatory Responses in FFA-Induced Hepatocyte Models via the EGR2-CD36 Axis},
journal = {Molecules},
year = {2026},
volume = {31},
number = {14},
pages = {2423},
doi = {10.3390/molecules31142423}
}
EUVIMED